Transforming Patient Support: Revolutionizing Payment & Travel Processes for a Multinational Pharmaceutical Company

A multinational pharmaceutical company sought to expand into a new therapeutic area and improve patient enrollment and retention. They partnered with Greenphire to standardize patient payment processes and travel arrangements, replacing previously inconsistent and inefficient methods that caused regulatory challenges.

Initially implemented at U.S. sites, Greenphire’s solutions led to an 11% increase in patient retention. Encouraged by this success, the sponsor expanded the partnership globally, achieving a 16% increase in site adoption. Study sites reported improved efficiency, with faster travel bookings and reimbursements. ClinCard users noted a significant reduction in administrative burdens, allowing patients to receive reimbursements more quickly.

The partnership extended across 30+ countries, covering over 150 studies with 80+ active trials, involving 1,500+ active sites and 5,000+ patients. To date, the company has paid over $2 million to participants using Greenphire’s automated financial management solutions.

Looking ahead, the sponsor plans to further scale Greenphire’s travel and payment solutions across additional countries. This commitment highlights their focus on enhancing patient-centric processes while optimizing financial management and trial operations.

Greenphire, backed by Thoma Bravo, specializes in software solutions for clinical trials, offering innovative travel and logistics support, automated payment systems, and trial budgeting analytics. By leveraging Greenphire’s technology, the pharmaceutical sponsor has significantly improved both patient and site experiences, demonstrating a strong commitment to innovation and efficiency in clinical research.